- Telehealth Visits
- Insurance plan information
Thomas Hope, MD
Diagnostic Radiology • Neuroendocrine Oncology- Telehealth Visits
- Insurance plan information
Thomas Hope, MD
Diagnostic Radiology • Neuroendocrine Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Thomas Hope is a radiologist and nuclear medicine physician (an expert in medical applications of radioactive substances). He specializes in neuroendocrine tumors, with a focus on peptide receptor radionuclide therapy, which targets these cancer cells with a high dose of radiation. He has a special interest in molecular imaging and in treating cancer using the targeted, individualized techniques of precision medicine.
In addition to working with patients, Hope conducts research on novel radiopharmaceuticals, or new radioactive imaging substances that can help physicians locate tumors. He also works on combining different imaging modalities – such as positron emission tomography and MRI – to stage cancer in patients.
Hope received his medical degree from Stanford University School of Medicine. He completed a residency in diagnostic radiology at UCSF. He then completed a fellowship in nuclear medicine and body MRI at Stanford.
Hope is a member of the Radiological Society of North America, Society of Nuclear Medicine and Molecular Imaging, Society of Abdominal Radiology and International Society for Magnetic Resonance in Medicine.
Education & training
Board certification
- Nuclear Medicine, American Board of Nuclear Medicine
- Diagnostic Radiology, American Board of Radiology
Fellowship
- Nuclear Medicine, Stanford University Medical Center-GME
Residency
- Radiology, General, UCSF Graduate Medical Education
Internship
- Internal Medicine, Kaiser Foundation Hospital - San Francisco
Degree
- MD, Stanford University School of Medicine
My expertise
Locations
My research
Clinical trials
Imaging of Solid Tumors Using FAP-2286Opens in a new window
Recruiting
The frequency and severity of treatment emergent adverse events following FAP-2286 injection will be descriptively reported as classified and graded by…18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid AdenomasOpens in a new window
Recruiting
Sensitivity of 18F-fluorocholine PET for the detection of abnormal parathyroid adenomas confirmed by pathology as compared to sestamibi imaging. Location of…Mechanisms of Resistance to PSMA Radioligand TherapyOpens in a new window
Recruiting
The unit density sphere model will be implemented using OLINDA, a second-generation personal computer software for internal dose assessment in nuclear…Comparison of Whole Body DWI to FDG PETOpens in a new window
Recruiting
The overall proportion of lesions that will be characterized as positive on whole body (WB) diffusion weight imaging (DWI) and FDG PET.
Publications
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.